Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 131.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Jun 2020 08:32

RNS Number : 5138P
Nationwide Building Society
10 June 2020
 

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO ANY U.S. PERSON OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

 

Nationwide Building Society announces proposed offering of Additional Tier 1 Securities and proposed issue of Core Capital Deferred Shares

 

10 June 2020. Nationwide Building Society (the "Society") is today launching a proposed offering, subject to customary offer restrictions, of sterling-denominated reset perpetual contingent convertible additional tier 1 securities (the "AT1 Securities"). The offer of the AT1 Securities is expected to price later today and to settle on or around 17 June 2020. The Society has appointed Citigroup Global Markets Limited, J.P. Morgan Securities plc, Merrill Lynch International and Morgan Stanley & Co. International plc as joint bookrunners (the "Joint Bookrunners") in connection with the offering of the AT1 Securities. The net proceeds of the issue of the AT1 Securities will be used by the Society to strengthen its regulatory capital base and for general business purposes consistent with the Society's principal purpose as a UK building society.

The Society has also separately agreed to issue 28,000 new Core Capital Deferred Shares ("CCDS") at an issue price of £162.041 per CCDS. The new CCDS are expected to be issued on or around 17 June 2020, and will be consolidated and form a single series with the Society's 10,500,000 CCDS currently outstanding. The net proceeds of the issue of the CCDS will be used to strengthen the Society's regulatory capital base, to satisfy prudential requirements with respect to discretionary awards and for general business purposes consistent with the Society's principal purpose as a UK building society.

For further information, please contact:

Alex Wall

Head of Financial Risk & Resource Optimisation

Telephone: +44 (0) 20 7261 6568

Email: Alexander.Wall@nationwide.co.uk

Nationwide Building Society

One Threadneedle Street

London EC2R 8AW

-----

DISCLAIMER

No representation has been made that any action has been or will be taken by the Society or any of the Joint Bookrunners that would permit a public offer of the securities referred to herein (the "Securities"), or possession or distribution of this announcement or any offering materials relating to the Securities (in preliminary, proof or final form) or any other offering or publicity material relating to the Securities (including roadshow materials and investor presentations) in any country or jurisdiction where action for that purpose is required. The Securities may not be, directly or indirectly, offered or sold in any country or jurisdiction where action for that purpose is required. Accordingly, the Securities may not, directly or indirectly, be offered or sold, and neither this announcement nor any offering materials relating to the Securities may be distributed in or from, or published in, any country or jurisdiction, except under circumstances that will result in compliance with any applicable laws and regulations.

United States. The Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except in certain transactions exempt from the registration requirements of the Securities Act.

Prohibition of sales to UK and EEA Retail Investors. The Securities have not been, and will not be, offered, sold or otherwise made available to any retail investor in the United Kingdom or the European Economic Area. For the purposes of this provision the expression "retail investor" means a person who is one (or more) of (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II") or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II.

United Kingdom. This announcement and any offering materials relating to the Securities are directed only at, and will be distributed only to, (i) persons who are outside the United Kingdom, (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 or (iii) those persons to whom it may otherwise lawfully be distributed (all such persons together being referred to as "relevant persons"). This announcement or any offering materials relating to the Securities is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity in relation to the Securities is available only to relevant persons and will be engaged in only with relevant persons. Any offering materials relating to the Securities will only be communicated to persons in the United Kingdom in circumstances where section 21(1) of the Financial Services and Markets Act 2000 would not, if the Society was not an authorised person, apply to the Society.

Additional offer and distribution restrictions apply in relation to the Securities in Italy, Canada and Singapore and may apply in other jurisdictions. The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement come are required by the Society and each of the Joint Bookrunners to inform themselves about, and to observe, any such restrictions. Nothing in this announcement constitutes an offer or sale of any Securities or a solicitation of an offer to purchase any Securities.

Compliance information for the Securities: MiFID II product governance - eligible counterparties and professional clients only; PRIIPs Regulation/FCA CoCo restriction/COBS 22.2 - no sales to United Kingdom or European Economic Area retail investors; no key information document has been or will be prepared.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFMMRTMTJBMBM
Date   Source Headline
20th Nov 20207:00 amRNSHalf-year Report
30th Oct 20201:46 pmRNSPublication of a Prospectus
18th Sep 20202:57 pmRNSResults of Tender Offers
18th Sep 202010:04 amRNSIndicative Results of Tender Offers
10th Sep 202011:24 amRNSTender Offer
1st Sep 202012:00 pmRNSDirectorate Change
27th Aug 20201:41 pmRNSPublication of Final Terms
21st Jul 20207:00 amRNSPublication of Final Terms
16th Jul 20201:35 pmRNSResult of AGM
10th Jul 20201:23 pmRNSPublication of Suppl.Prospcts
18th Jun 202010:11 amRNSInitial admission - Offcl Lst
17th Jun 20201:00 pmRNSHolding(s) in Company
15th Jun 202012:20 pmRNSPublication of a Prospectus
10th Jun 20208:32 amRNSIssue of Equity
29th May 20207:00 amRNSAnnual Financial Report
3rd Apr 20207:00 amRNSNationwide for Business
10th Mar 20207:00 amRNSDirectorate Change
13th Feb 20203:30 pmRNSPublication of Final Terms
6th Feb 20204:03 pmRNSPublication of a Prospectus
27th Jan 202011:30 amRNSPublication of Final Terms
22nd Jan 20203:00 pmRNSPublication of Final Terms
22nd Jan 20207:00 amRNSNotice to Bondholders
20th Jan 20201:00 pmRNSAppointment of Senior Independent Director
16th Dec 20195:49 pmRNSResponse to Results of BOE Stress Test 2019
25th Nov 20191:33 pmRNSPublication of Suppl.Prospcts
22nd Nov 20197:00 amRNSHalf-year Report
7th Nov 20192:04 pmRNSNotice of Pricing Results
7th Nov 20199:55 amRNSNotice of Results of Bondholder Meeting
4th Nov 201911:10 amRNSPublication of a Prospectus
16th Oct 201910:43 amRNSNotice to Bondholders
20th Sep 20195:12 pmRNSPublication of Offering Circular
13th Sep 20197:00 amRNSUpdate on Payment Protection Insurance
2nd Sep 20197:00 amRNSNon Executive Director Changes
27th Aug 201912:43 pmRNSPublication of Final Terms
16th Aug 201911:35 amRNSPublication of Final Terms
18th Jul 20193:11 pmRNSResult of AGM
17th Jul 201911:07 amRNSPublication of Final Terms
17th Jul 20199:00 amRNSDirectorate Change
15th Jul 20194:06 pmRNSPublication of a Prospectus
15th Jul 201912:13 pmRNSPost-stabilisation notice - NWIDE
25th Jun 20193:59 pmRNSPublication of a Prospectus
22nd May 20198:27 amRNSPre-Stabilisation Notice - Nationwide 5yr EUR Cov
21st May 20194:57 pmRNSPublication of Suppl.Prospcts
21st May 20197:00 amRNSAnnouncement of CFO's Intention to Retire
21st May 20197:00 amRNSPreliminary Results Announcement 2018/19
14th May 20195:43 pmRNSCCDS - Adjustment to PIR Cap
24th Apr 201912:00 pmRNSNotice of Redemption
8th Feb 20191:24 pmRNSPublication of Suppl.Prospcts
8th Feb 20197:00 amRNSInterim Management Statement 31 December 2018
11th Jan 201911:31 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.